series of quinoline-substituted dihydroindoles has been synthesized an
d evaluated as antagonists of the cysLT(1) receptor. This series, exem
plified by 2 (LY302905, pKi = 8.3 for inhibition of binding of H-3-LTD
(4) to guinea pig lung membranes), represents reduced analogues of the
corresponding indoles that were previously shown to be potent, orally
active cysLT(1) receptor antagonists. These dihydroindole compounds g
enerally displayed increased in vitro and in vivo (oral) activity.